CureVac Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	53.76	67.42	102.99	48.87	17.42	Upgrade
Revenue Growth (YoY)	-20.26%	-34.54%	110.74%	180.61%	35.31%	Upgrade
Cost of Revenue	124.37	183.99	238.2	14.17	27.98	Upgrade
Gross Profit	-70.61	-116.57	-135.21	34.7	-10.57	Upgrade
Selling, General & Admin	95.67	107	102.15	54.29	50.72	Upgrade
Research & Development	115.72	62.55	815.91	113.81	43.24	Upgrade
Other Operating Expenses	-7.8	-36.66	-640.99	-23.58	-5.04	Upgrade
Operating Expenses	203.6	132.88	277.06	144.51	88.93	Upgrade
Operating Income	-274.21	-249.46	-412.26	-109.82	-99.5	Upgrade
Interest Expense / Income	2.49	3.71	10.34	22.1	1.46	Upgrade
Other Expense / Income	-16.73	-4.01	-10.1	-2.07	-0.83	Upgrade
Pretax Income	-259.97	-249.16	-412.5	-129.85	-100.13	Upgrade
Income Tax	0.2	-0.13	-0.78	-0.73	-0.25	Upgrade
Net Income	-260.17	-249.03	-411.72	-129.12	-99.87	Upgrade
Shares Outstanding (Basic)	224	190	187	176	176	Upgrade
Shares Change	17.68%	1.73%	6.00%	-	-	Upgrade
EPS (Basic)	-1.18	-1.32	-2.21	-0.98	-1.03	Upgrade
EPS (Diluted)	-1.18	-1.32	-2.21	-0.98	-1.03	Upgrade
Free Cash Flow	-320.21	-374.2	-857.35	486.07	-98.14	Upgrade
Free Cash Flow Per Share	-1.43	-1.97	-4.58	2.75	-0.56	Upgrade
Gross Margin	-131.34%	-172.91%	-131.28%	71.00%	-60.67%	Upgrade
Operating Margin	-510.08%	-370.00%	-400.29%	-224.70%	-571.30%	Upgrade
Profit Margin	-483.96%	-369.37%	-399.76%	-264.21%	-573.46%	Upgrade
Free Cash Flow Margin	-595.65%	-555.03%	-832.46%	994.61%	-563.48%	Upgrade
EBITDA	-234.09	-221.71	-386.49	-97.07	-91.5	Upgrade
EBITDA Margin	-435.45%	-328.84%	-375.27%	-198.63%	-525.38%	Upgrade
Depreciation & Amortization	23.39	23.74	15.67	10.67	7.16	Upgrade
EBIT	-257.48	-245.45	-402.16	-107.75	-98.67	Upgrade
EBIT Margin	-478.95%	-364.06%	-390.48%	-220.47%	-566.52%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).